Anti-ERBB2 Antibody (CBMAB-CA015LY) Immunohistochemistry Kit (V2LY-0826-LY183)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Components References Q & As Review & reward Protocols Associated Products

Summary

Product Overview
This comprehensive, all-in-one kit is designed for the precise immunohistochemical (IHC) detection of target protein in tissue samples. Unlike standard detection kits, it includes a highly specific mouse primary antibody bundled directly with our robust Polymer HRP detection system. The kit provides every essential reagent needed for the entire IHC workflow-from the initial antigen retrieval buffer to the final mounting media. By offering a pre-matched primary antibody with optimized buffers and secondary detection reagents, this kit eliminates the need for tedious protocol optimization and reagent sourcing, ensuring consistent, high-quality staining results.
Primary Antibody Cat.
Primary Antibody
Secondary Antibody Host Species
Goat
Secondary Antibody Species Specificity
Mouse
Application
IHC-P
Sample Type
FFPE tissue
Test Size
50 Tests
Storage
Stored at 2-8°C. The kit is stable for 6 months from the date of receipt.

Key Features

Target-Specific Primary Antibody
Includes a highly validated mouse primary antibody, ensuring reliable and specific target localization.
Complete End-to-End Solution
Contains all 11 essential components required for a full IHC workflow, including Tris-EDTA Antigen Retrieval Buffer, Blocking Buffer, Polymer HRP-Goat anti-Mouse Secondary Antibody, DAB Chromogens, Counterstain, and Mounting Media.
Streamlined Workflow
Pre-optimized reagents work seamlessly with the included primary antibody, saving researchers significant time on antibody titration and protocol adjustments.
Sample Compatibility
Highly recommended and optimized for Formalin-Fixed Paraffin-Embedded (FFPE) tissue sections.
Kit Capacity
Provides sufficient reagents (50T) to perform 50 tests, depending on tissue section size.
More Infomation
Sub Cat Reagents Size
LV01 Antigen Retrieval Buffer (50× Tris-EDTA) 100 ml
LV02 Washing Buffer (30×) 120 ml
LV03 Blocking Buffer 5 ml
LV04 Quenching buffer (RTU) 5 ml
LV05 Primary Antibody Diluent (RTU) 100 ml
LV06M HRP-Goat anti-Mouse Secondary Antibody 5 ml
LV07 Chromogen Component A 0.2 ml
LV08 Chromogen Component B 4 ml
LV09 Signal Enhancer 5 ml
LV10 Counter Staining Reagent 5 ml
LV11 Mounting Media 5 ml

Tarantino, P., Jin, Q., Tayob, N., Jeselsohn, R. M., Schnitt, S. J., Vincuilla, J., ... & Tolaney, S. M. (2022). Prognostic and biologic significance of ERBB2-low expression in early-stage breast cancer. JAMA oncology, 8(8), 1177-1183.

Abuhelwa, Z., Alloghbi, A., Alqahtani, A., & Nagasaka, M. (2022). Trastuzumab deruxtecan-induced interstitial lung disease/pneumonitis in ERBB2-positive advanced solid malignancies: a systematic review. Drugs, 1-9.

Tarantino, P., Modi, S., Tolaney, S. M., Cortés, J., Hamilton, E. P., Kim, S. B., ... & Curigliano, G. (2021). Interstitial lung disease induced by anti-ERBB2 antibody-drug conjugates: a review. JAMA oncology, 7(12), 1873-1881.

Rugo, H. S., Im, S. A., Cardoso, F., Cortés, J., Curigliano, G., Musolino, A., ... & SOPHIA Study Group. (2021). Efficacy of margetuximab vs trastuzumab in patients with pretreated ERBB2-positive advanced breast cancer: a phase 3 randomized clinical trial. JAMA oncology, 7(4), 573-584.

Bychkov, D., Linder, N., Tiulpin, A., Kücükel, H., Lundin, M., Nordling, S., ... & Lundin, J. (2021). Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy. Scientific reports, 11(1), 1-10.

Aharonov, A., Shakked, A., Umansky, K. B., Savidor, A., Genzelinakh, A., Kain, D., ... & Tzahor, E. (2020). ERBB2 drives YAP activation and EMT-like processes during cardiac regeneration. Nature cell biology, 22(11), 1346-1356.

Zhang, J., Liu, S., Li, Q., Shi, Y., Wu, Y., Liu, F., ... & Liu, H. (2020). The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer. Cell Death & Differentiation, 27(9), 2710-2725.

Subramanian, J., Katta, A., Masood, A., Vudem, D. R., & Kancha, R. K. (2019). Emergence of ERBB2 mutation as a biomarker and an actionable target in solid cancers. The Oncologist, 24(12), e1303-e1314.

Sanchez-Vega, F., Hechtman, J. F., Castel, P., Ku, G. Y., Tuvy, Y., Won, H., ... & Janjigian, Y. Y. (2019). EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric CancerAfatinib in ERBB2-Amplified Gastric Cancer. Cancer discovery, 9(2), 199-209.

Honkoop, H., de Bakker, D. E., Aharonov, A., Kruse, F., Shakked, A., Nguyen, P. D., ... & Bakkers, J. (2019). Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart. Elife, 8, e50163.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Anti-ERBB2 Antibody (CBMAB-CA015LY) Immunohistochemistry Kit?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...

Alternative Versions

Canine Recombinant ERBB2 protein, His Tag (CAT#: V2LY-0526-LY1259)

Cynomolgus Recombinant ERBB2 protein, ECD, hFc Tag (CAT#: V2LY-0526-LY1531)

Cynomolgus Recombinant ERBB2 protein, His Tag (CAT#: V2LY-0526-LY1532)

Human Recombinant ERBB2 (A775_G776insYVMA, C805S), Active protein, GST Tag (CAT#: V2LY-0526-LY4484)

Human Recombinant ERBB2 (A775_G776insYVMA), Active protein, GST Tag (CAT#: V2LY-0526-LY4485)

Human Recombinant ERBB2 (A775_G776insYVMA), Active protein, GST Tag-1 (CAT#: V2LY-0526-LY4486)

Human Recombinant ERBB2 protein, GST Tag (CAT#: V2LY-0526-LY4487)

Human Recombinant ERBB2 protein, ECD, AF647 Conjugated, His Tag (CAT#: V2LY-0526-LY4488)

Human Recombinant ERBB2 protein, ECD, APC Conjugated, His Tag (CAT#: V2LY-0526-LY4489)

Human Recombinant ERBB2 (C805S), Active protein, GST Tag (CAT#: V2LY-0526-LY4490)

Related Products

Human Recombinant ERBB2 (R896C), Active protein, GST Tag (CAT#: V2LY-0526-LY4520)

Mouse Anti-ERBB2 Recombinant Antibody (CB190) (CAT#: CBMAB-CS190LY)

Human Recombinant ERBB2 proteinECD-1 (CAT#: V2LY-0526-LY4498)

Human Recombinant ERBB2 (A775_G776insYVMA, C805S), Active protein, GST Tag (CAT#: V2LY-0526-LY4484)

Human Recombinant ERBB2 protein, ECD, His Tag (CAT#: V2LY-0526-LY4506)

Human Recombinant ERBB2 (Domain IV) protein, ECD, His Tag-1 (CAT#: V2LY-0526-LY4501)

Human Recombinant ERBB2 (d755-759), Active protein, GST Tag (CAT#: V2LY-0526-LY4491)

Rabbit Anti-ERBB2 (Phospho-Tyr1248) Recombinant Antibody (D7) (CAT#: PTM-CBMAB-0630LY)

Human Recombinant ERBB2 (A775_G776insYVMA), Active protein, GST Tag-1 (CAT#: V2LY-0526-LY4486)

Mouse Anti-ERBB2 Recombinant Antibody (CB357A) (CAT#: CBMAB-CA357LY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.